raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:251274

Familial hyperaldosteronism type III

Synonyms: FH-III · FH3 · Familial hyperaldosteronism type 3

Type
Disease
Group
Disorder
Inheritance
Autosomal dominant
Age of onset
Adolescent, Childhood, Infancy
Status
active

A rare heritable form of primary aldosteronism (PA) that is characterized by early-onset severe hypertension, non- glucocorticoid-remediable hyperaldosteronism, overproduction of 18-oxocortisol and 18-hydroxycortisol, and profound hypokalemia.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enFamilial hyperaldosteronism type IIIFH-III · FH3 · Familial hyperaldosteronism type 3
frHyperaldostéronisme familial type IIIFH-III · FH3 · Hyperaldostéronisme familial type 3
deHyperaldosteronismus, familiärer, Typ IIIFH-III · FH3 · Familiärer Hyperaldosteronismus Typ 3
esHiperaldosteronismo familiar tipo IIIFH-III · FH3 · Hiperaldosteronismo familiar tipo 3
itIperaldosteronismo familiare, tipo IIIFH3 · Iperaldosteronismo familiare, tipo 3 · FH-III
nlFamiliaal hyperaldosteronisme type IIIFH-III · FH3 · Familiaal hyperaldosteronisme type 3
ptHiperaldosteronismo familiar, tipo 3
plRodzinny hiperaldosteronizm typu IIIFH3 · FH-III · Rodzinny hiperaldosteronizm typu 3
csFamiliární hyperaldosteronismus, typ IIIFH-III · FH3 · Familiární hyperaldosteronismus, typ 3
ukСімейний гіперальдостеронізм, тип IIIСімейний гіперальдостеронізм типу 3 · FH3 · FH-III
zhIII型家族性醛固酮增多症3型家族性醛固酮增多症
trAilesel hiperaldosteronizm tip IIIFH3 · FH-III · Ailesel hiperaldosteronizm tip 3

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM613677Evalidated
ICD-10E26.0NTBTattributedvalidated
ICD-115A72.0NTBTindexvalidated
MONDO0013359Evalidated
UMLSC3838758Evalidated
GARD12362Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (1):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
KCNJ5Disease-causing germline mutation(s) (gain of function) inAssessedHGNC:6266ENSG0000012045760073411q24.3potassium inwardly rectifying channel subfamily J member 524817817[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families7 familiesWorldwideFamily(ies)Validated24037882[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

17 annotations · validated 2016-08-29
HPOTerm (as annotated by Orphanet)Diagnostic
Obligate (100%)
HP:0040084Abnormal circulating renin
HP:0000822Hypertension
Very frequent (99-80%)
HP:0008221Adrenal hyperplasia
HP:0011740Glucocortocoid-insensitive primary hyperaldosteronism
HP:0002900Hypokalemia
Occasional (29-5%)
HP:0000421Epistaxis
HP:0002315Headache
HP:0002150Hypercalciuria
HP:0002170Intracranial hemorrhage
HP:0001712Left ventricular hypertrophy
HP:0200114Metabolic alkalosis
HP:0001324Muscle weakness
HP:0002018Nausea
HP:0001959Polydipsia
HP:0001657Prolonged QT interval
HP:0000360Tinnitus
Excluded (0%)
HP:0011739Dexamethasone-suppresible primary hyperaldosteronism

Run the differential on the 5 obligate / very frequent terms

Annotation source: 18505761[PMID]_23229280[PMID]_21311022[PMID]_26934393[PMID]_27036860[PMID]_27403928[PMID]

7

Sources for this card